原生细胞,微质细胞和非编码RNA:质母细胞病变和治疗耐药性的主导者
Adil Husain1, Firoz Ahmad2, Sandeep Pandey3
1Department of Biochemistry, Babu Banarasi Das College of Dental Sciences, Babu Banarasi Das University, Lucknow, 226028, Uttar Pradesh, India.
Non-coding RNA research
|September 2, 2025
概括
质母细胞瘤 (GB) 具有攻击性和耐治疗性. 主细胞,微质细胞和非编码RNA (ncRNA) 驱动GB的生长和抵抗,提供新的治疗点.
科学领域:
- 神经瘤学
- 癌症生物学
- 分子生物学
背景情况:
- 由于其侵袭性和对标准治疗的耐药性,质母细胞瘤 (GB) 存在重大治疗挑战.
- 质瘤干细胞 (GSCs) 源自原始细胞,是瘤发病,复发和治疗耐药性的关键驱动因素.
- 大脑的免疫细胞,微质细胞, 被GB操纵, 促进免疫抑制环境, 促进瘤的进展和避开治疗.
研究的目的:
- 审查原生细胞,微质细胞和非编码RNAs (ncRNAs) 在质母细胞瘤发病过程中的复杂作用.
- 阐明这些成分如何导致质母细胞瘤的耐药性.
- 探索针对这些分子参与者的新疗法,以改善质母细胞瘤治疗结果.
主要方法:
- 专注于质母细胞,原生细胞,微质细胞和非编码RNA的文献综述.
- 对质母细胞瘤发病,进展和耐药性的分子机制的分析.
- 关于细胞组件和ncRNAs在质母细胞微环境中的相互作用的当前研究综合.
主要成果:
- 原生细胞 (作为GSCs) 具有可塑性,并驱动瘤复发和抵抗.
- 微细胞被质母细胞吸收,形成一个免疫抑制的瘤微环境.
- 非编码RNAs (miRNAs, lncRNAs) 调节基因表达和调节相互作用,从而影响抗性机制.
结论:
- 了解原生细胞,小质细胞和ncRNA的复杂作用对于解决质母细胞瘤至关重要.
- 针对这些相互关联的途径为克服质母细胞瘤治疗抵抗提供了有希望的策略.
- 对这些分子参与者的进一步研究可能会改善质母细胞瘤患者的临床结果.
更多相关视频
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
9.7K
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.7K
相关概念视频
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:28Biosynthesis of Nucleic Acids
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...